Published in Gene Therapy Weekly, July 31st, 1995
The study was reported in the July 14, 1995, issue of the scientific journal Cell.
The research, conducted by Dr. Eva Turley at the Manitoba Institute of Cell Biology, has produced evidence that when HA is directed to ras, the gene suspected of causing 20-30 percent of all cancers, ras is prevented from mutating and starting the tumor-making process. The HA is applied to ras via another gene, RHAMM, which...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.